These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26517496)

  • 1. Mutant prevention concentration of tigecycline for Klebsiella pneumoniae isolates with four different resistance statuses.
    Zhong X; Xu HT; Chen DK; Hu X; Cheng G
    J Infect Dev Ctries; 2015 Oct; 9(10):1177-9. PubMed ID: 26517496
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutant prevention concentration of tigecycline for Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Peck KR; Ko KS
    J Antimicrob Chemother; 2015 Feb; 70(2):621-2. PubMed ID: 25304645
    [No Abstract]   [Full Text] [Related]  

  • 3. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital.
    Neonakis IK; Stylianou K; Daphnis E; Maraki S
    Indian J Med Microbiol; 2011; 29(1):78-9. PubMed ID: 21304206
    [No Abstract]   [Full Text] [Related]  

  • 4. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.
    Hentschke M; Wolters M; Sobottka I; Rohde H; Aepfelbacher M
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2720-3. PubMed ID: 20350947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
    He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
    PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Resistance Mechanism and Clonal Distribution of Tigecycline-Nonsusceptible Klebsiella pneumoniae Isolates in Korea.
    Ahn C; Yoon SS; Yong TS; Jeong SH; Lee K
    Yonsei Med J; 2016 May; 57(3):641-6. PubMed ID: 26996563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
    Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates.
    Sheng ZK; Hu F; Wang W; Guo Q; Chen Z; Xu X; Zhu D; Wang M
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6982-5. PubMed ID: 25182649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
    Roy S; Datta S; Viswanathan R; Singh AK; Basu S
    J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
    Lin YT; Huang YW; Huang HH; Yang TC; Wang FD; Fung CP
    Int J Antimicrob Agents; 2016 Nov; 48(5):485-491. PubMed ID: 27575728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.
    Zhang Y; Li P; Yin Y; Li F; Zhang Q
    J Antibiot (Tokyo); 2017 Feb; 70(2):193-195. PubMed ID: 27460764
    [No Abstract]   [Full Text] [Related]  

  • 14. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital.
    Zhong X; Xu H; Chen D; Zhou H; Hu X; Cheng G
    PLoS One; 2014; 9(12):e115185. PubMed ID: 25503276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline Resistant Klebsiella pneumoniae Isolated from Austrian River Water.
    Hladicz A; Kittinger C; Zarfel G
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 28972552
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence and characterization of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae isolates from blood samples of patients in intensive care units in northern China.
    Xu H; Zhou Y; Zhai X; Du Z; Wu H; Han Y; Huo C; Chen Y
    J Med Microbiol; 2016 Aug; 65(8):751-759. PubMed ID: 27324378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline resistance among Klebsiella pneumoniae isolated from febrile neutropenic patients.
    Elgendy SG; Abdel Hameed MR; El-Mokhtar MA
    J Med Microbiol; 2018 Jul; 67(7):972-975. PubMed ID: 29799385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of
    Chiu SK; Huang LY; Chen H; Tsai YK; Liou CH; Lin JC; Siu LK; Chang FY; Yeh KM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo development of tigecycline resistance in Klebsiella pneumoniae owing to deletion of the ramR ribosomal binding site.
    Ye M; Ding B; Qian H; Xu Q; Jiang J; Huang J; Ou H; Hu F; Wang M
    Int J Antimicrob Agents; 2017 Oct; 50(4):523-528. PubMed ID: 28668690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.